RNA Integrity Assessment via qPCR Cτ Profiles
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for assessing RNA integrity, such as the Agilent 2100 Bioanalyzer, lack sensitivity and cannot predict the functional performance of RNA samples in gene expression analysis, leading to variability and errors in large-scale gene expression studies.
Innovation Solution
A high-throughput method involving the identification of candidate genes specific to a tissue or blood specimen, determination of expression scores, and generation of Cτ profiles to quantify RNA degradation, with novel class distinction algorithms to measure RNA quality and exclude subpar samples.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If microcapillary electrophoretic RNA separation (Bioanalyzer) is used to assess RNA integrity, then a gross analytical assessment is provided, but sensitivity and ability to predict functional performance are insufficient
Solution Approach 1:
The patent replaces the mechanical microcapillary electrophoresis system (Bioanalyzer) with a biochemical qPCR-based assessment system. Instead of physically separating RNA molecules by size through electrophoresis, the invention uses quantitative PCR to amplify and detect specific RNA regions, providing more sensitive functional integrity assessment through biochemical amplification and detection mechanisms.
Solution Approach 2:
The invention changes the assessment parameters from gross structural evaluation (overall RNA size distribution) to functional parameter measurement (amplification efficiency and Cτ values of specific genes). By monitoring how specific RNA regions amplify during qPCR, the system detects subtle degradation patterns that correlate with functional performance in gene expression studies.
2Reliability
If broad-spectrum RNA integrity systems are used, then multiple visualization methods are provided, but they cannot adequately predict functional performance for gene expression analysis
Solution Approach 1:
Instead of assessing overall RNA quality uniformly, the invention evaluates specific local regions of RNA molecules by targeting particular genes with known degradation patterns. Different genes serve as local probes for different aspects of RNA integrity, providing localized functional predictions that are more reliable for gene expression analysis than global assessments.
Solution Approach 2:
The patent introduces specific candidate genes as intermediary markers between RNA structural integrity and functional performance. These genes act as mediators whose amplification characteristics reflect the functional state of RNA samples, bridging the gap between physical integrity measurements and actual gene expression analysis outcomes.
3Productivity
If RNA samples are subjected to extensive processing and storage, then large-scale gene expression studies are enabled, but RNA degradation occurs leading to variability and technical errors
Solution Approach 1:
The invention performs preliminary quality assessment using qPCR on RNA samples before they are used in large-scale gene expression studies. By evaluating amplification efficiency and Cτ values of candidate genes in advance, the system identifies and excludes degraded samples, preventing them from introducing variability and technical errors into subsequent high-throughput analyses.
Solution Approach 2:
The patent implements a feedback mechanism where qPCR assessment results directly inform the decision to include or exclude samples from gene expression studies. The amplification data provides real-time feedback on RNA integrity, allowing researchers to adjust sample selection and processing protocols to maintain reliability while preserving productivity.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach provides a sensitive and standardized method for evaluating RNA integrity, reducing sample replicate variability and technical errors, and ensuring reliable gene expression data by correlating Cτ scores with intact and degraded RNA profiles.
Implementation Method 1
The test sample is subjected to qPCR, and an amplification plot and a Cτ, score generated
Data Source
AI summary
Methods for assessing the integrity of an RNA sample from a given tissue or blood type are disclosed.